Cross Net Income From Continuing Ops from 2010 to 2026

CCRN Stock  USD 9.32  0.15  1.64%   
Cross Country Net Loss yearly trend continues to be very stable with very little volatility. Net Loss is likely to grow to about -15.9 M this year. During the period from 2010 to 2026, Cross Country Net Loss quarterly data regression pattern had sample variance of 4155.2 T and median of  4,097,849. View All Fundamentals
 
Net Loss  
First Reported
2000-03-31
Previous Quarter
-6.7 M
Current Value
-4.8 M
Quarterly Volatility
15.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Cross Country financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cross Country's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.3 M, Interest Expense of 2.4 M or Selling General Administrative of 152.6 M, as well as many indicators such as Price To Sales Ratio of 0.77, Dividend Yield of 2.0E-4 or PTB Ratio of 2.22. Cross financial statements analysis is a perfect complement when working with Cross Country Valuation or Volatility modules.
  
Build AI portfolio with Cross Stock
Check out the analysis of Cross Country Correlation against competitors.
Evaluating Cross Country's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Cross Country Healthcare's fundamental strength.

Latest Cross Country's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Cross Country Healthcare over the last few years. It is Cross Country's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cross Country's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Pretty Stable
   Net Income From Continuing Ops   
       Timeline  

Cross Net Income From Continuing Ops Regression Statistics

Arithmetic Mean18,948,365
Geometric Mean22,613,375
Coefficient Of Variation340.19
Mean Deviation47,185,678
Median4,097,849
Standard Deviation64,461,170
Sample Variance4155.2T
Range244.4M
R-Value0.24
Mean Square Error4168.4T
R-Squared0.06
Significance0.35
Slope3,114,625
Total Sum of Squares66483.9T

Cross Net Income From Continuing Ops History

2026-15.9 M
2025-16.7 M
2024-14.6 M
2023102.4 M
2022188.5 M
2021132 M
2020-12.1 M

About Cross Country Financial Statements

Cross Country investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Cross Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-16.7 M-15.9 M

Pair Trading with Cross Country

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.

Moving against Cross Stock

  0.85OCA Oceania HealthcarePairCorr
  0.79RMY Ramsay Health CarePairCorr
  0.74SPGX Sustainable ProjectsPairCorr
  0.73BTSG BrightSpring HealthPairCorr
  0.73H Hyatt HotelsPairCorr
The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.
The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:
Check out the analysis of Cross Country Correlation against competitors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Health Care Providers & Services sector continue expanding? Could Cross diversify its offerings? Factors like these will boost the valuation of Cross Country. Projected growth potential of Cross fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cross Country data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.79)
Earnings Share
(0.49)
Revenue Per Share
34.789
Quarterly Revenue Growth
(0.21)
Return On Assets
0.0048
Understanding Cross Country Healthcare requires distinguishing between market price and book value, where the latter reflects Cross's accounting equity. The concept of intrinsic value—what Cross Country's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Cross Country's price substantially above or below its fundamental value.
It's important to distinguish between Cross Country's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cross Country should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cross Country's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.